,0
0,Health Canada Grants Market Authorization for TRIKAFTAÂ® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 2 To 5 Years With At Least One F508del Mutation
1,Why Vertex (VRTX) is Poised to Beat Earnings Estimates Again
2,Vertex Pharmaceuticals (VRTX) Increases Yet Falls Behind Market: What Investors Need to KnowZacks
3,Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?Zacks
4,"Dollar Tree upgraded, Microsoft initiated: Wall Street's top analyst calls"
5,Vertex Pharmaceuticals (VRTX) Increases Yet Falls Behind Market: What Investors Need to Know
6,2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
7,"This Cathie Wood Stock Is Set to Soar 100%, Says Wall Street"
8,Is Vertex Pharmaceuticals Stock a Buy Now?
9,Vertex Pharmaceuticals (VRTX) Increases Yet Falls Behind Market: What Investors Need to KnowZacks
10,Why Vertex (VRTX) is Poised to Beat Earnings Estimates AgainZacks
11,Vertex Pharmaceuticals: One Chart Explains the Mega Rally
12,Here's Why You May Invest in CRISPR Therapeutics (CRSP) Stock
13,The Surprising $5 Billion Opportunity That Drove Vertex Pharmaceuticals Stock To A Record High
